We are excited to share that our Quris AI team has published a groundbreaking article on multi-organ models for neurotoxicity assessment, featuring our BioAI platform in action. The study demonstrates the power of combining liver spheroids and brain organoids to improve drug safety predictions. This model offers a more accurate assessment of drug-induced neurotoxicity, making it a crucial advancement in personalized medicine and drug development. Check out the article and learn how our AI-driven platform is transforming drug safety and longevity innovation! 🔗 https://lnkd.in/dPDVmud8 #QurisAI #DrugDevelopment #BioAI #AIinHealthcare #Neurotoxicity #Longevity #PersonalizedMedicine #InnovativeTech #FutureOfHealth #LifeSciences #AI
Quris AI
Biotechnology Research
Boston, Massachusetts 3,387 followers
Leading the AI-Pharma Revolution
About us
Quris-AI is an artificial intelligence innovator that is disrupting drug development. Its machine-learning bio-platform better predicts which drug candidates will safely work in humans, avoiding tremendous costs of failed clinical trials. Quris-AI is led by a track-record team of top scientists and strategic investors. Its first AI-based drug is now prepping for clinical testing.
- Website
-
https://www.quris.ai/
External link for Quris AI
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Boston, Massachusetts
- Type
- Privately Held
Locations
-
Primary
Boston, Massachusetts, US
Employees at Quris AI
-
Alex Bronstein
-
Orit Shaked
Corporate strategy, Commercial operations, Entrepreneurship
-
Michael Salaverry
Data | Dashboards | Innovation | Software Engineering
-
Nurit Tweezer-Zaks MD MBA
Translating Innovation into Market-Driven, Applicable Solutions | Clinical, Research, and Commercial Verticals. Experienced Executive in Pharma…
Updates
-
Quris AI Proudly Sponsors the Wellness & Longevity vertical and the HealthTech vertical at the first-ever Israel Tech Week in Miami, happening from March 27 – April 3, 2025. As leaders in AI-powered drug safety and innovation, we’re thrilled to be part of an event that brings together pioneers, investors, scientists, and industry experts to explore the future of health, wellness, and longevity. A special thanks to Amir Alroy, who will moderate the Wellness & Longevity vertical. Amir and Welltech Ventures have been incredible partners to Quris-AI, and we’re excited to work together in shaping the future of this space. Join us for insightful discussions, cutting-edge research, and startup showcases highlighting Israel’s leadership in wellness innovation, AI-driven health solutions, and longevity science. #QurisAI #Wellness #Longevity #HealthTech #IsraelTechWeek #Innovation #AIinHealthcare #FutureOfHealth
-
-
We’re excited to announce that Quris-AI will be part of the 2025 Innovative Practices Awards (IPA) at the Bio-IT World Conference & Expo, taking place April 2–4 in Boston! Our BioAI platform has been recognized for its innovative approach to de-risking, accelerating, and personalizing drug development. Dr. Amir Bein, our VP of Biology, will be presenting on how Quris-AI is leveraging AI to drive breakthroughs in drug safety and personalized medicine. Join us on April 4th from 10:30 a.m. to 12:10 p.m. in the Data Management track for a dedicated session featuring award-winning teams. We will share the strategies and technologies that set our work apart. This is a unique opportunity to learn from industry leaders and discover cutting-edge innovations in AI-powered drug development and digital health. We look forward to seeing you there! 🔗https://lnkd.in/g5Ae2Pq6 #BioITWorld #Innovation #BioAI #DrugDevelopment #AIinHealthcare #LifeSciences #TechForHealth #BioITExpo #IPA2025
-
-
Quris AI Recognized for Innovation at Bio-IT World 2025! 🌟 We are honored to have received an Honorable Mention at the Bio-IT World Innovative Practices Awards 2025 for our BioAI platform! Our Head of Biology, Dr. Amir Bein, will be joining the speaking panel and is also featured on the speaker page and agenda for the upcoming event. We are excited for the future and looking forward to more groundbreaking advancements! https://lnkd.in/epfeCMii #QurisAI #BioAI #DrugDevelopment #Innovation #Biotech #AIinHealthcare #FutureOfMedicine #BioITWorld2025
-
We were honored to participate in Drug R&D 2025, where our VP of Biology, Dr. Amir Bein, had the opportunity to present and engage with leading experts in the field. The insights shared have further fueled our commitment to revolutionizing drug development and fostering a collaborative community of industry leaders, researchers, young innovators, and government officials. We hope to continue collaborating and driving meaningful progress together! 🔬💡 Let’s shape the future of drug discovery! #DrugRND #QurisAI #AIinPharma #BiotechInnovation #FutureOfMedicine
-
-
🚨 We’re LIVE at #SOT2025! 🚨 Come visit us at Booth #1265 at the Society of Toxicology (SOT) Annual Meeting & ToxExpo in Orlando! ☕ Fuel up with coffee (and hit your caffeine Cmax 😉) 🧬 Learn how our AI-powered Bio-AI platform predicts DILI with unmatched accuracy 🤝 Meet our team and explore how we can collaborate Swing by to see how we’re revolutionizing drug safety prediction. See you at Booth #1265! #SOT #DrugSafety #AI #BioAI #DILI #Toxicology #SOT2025
-
-
Quris-AI is heading to SOT 2025! We’re excited to exhibit at the 64th Annual SOT Meeting & ToxExpo in Orlando, Florida, March 16-20, 2025! Visit us at Booth #1265 to discover how we are revolutionizing drug safety prediction with our AI-powered Bio-AI platform. Let's connect and explore the future of predictive toxicology—reducing drug failure rates and enhancing patient safety through cutting-edge technology. #SOT2025 #ToxExpo #DrugSafety #AIinPharma #Biotech #PharmaInnovation #QurisAI
-
-
Revolutionizing Drug Development with Bio-AI 🔬 At Abu Dhabi Global Healthcare Week, our Founder and CEO, Isaac Bentwich, explored how AI is reshaping drug development—eliminating reliance on animal testing, predicting patient safety with greater accuracy, and accelerating clinical trials. As the industry moves toward a smarter, more ethical future, Bio-AI is leading the way in ensuring safer, faster, and more cost-effective drug discovery. #BioAI #DrugSafety #FutureofMedicine #ADGHW #AIinHealthcare #QurisAI
Speaking about health equity, Isaac Bentwich - Founder and CEO of Quris AI Technologies Ltd. delves into the role of AI in revolutionizing drug development and testing programs. This new investigational drug process can greatly reduce reliance on animal testing, saving time and resources in drug development. Recorded at Abu Dhabi Global Healthcare Week 2024. Learn more at www.adghw.com #ADGHW #AbuDhabi #DoH #FutureofHealthcare #GlobalHealthcare Hadley Gamble Department of Health Abu Dhabi
-
Quris AI reposted this
Quris AI is pioneering AI-driven drug development. Traditional clinical trials are expensive and can be inaccurate, but Quris' Bio-AI Clinical Prediction Platform is changing that. By integrating AI with patient-on-chip technology, Quris is creating safer, more efficient drug testing processes—revolutionizing the pharma industry. See how this innovation is reshaping medicine: https://bit.ly/3MaBoCa #PharmaInnovation #ArtificialIntelligence #InsideTheBlueprint #DrugDevelopment #BioTech
-
Predicting Patient Safety with Precision 🏆 Traditional drug testing models are riddled with uncertainty, leading to costly failures and patient risks. By integrating AI-driven insights with organ-on-a-chip technology, drug safety can now be predicted with unmatched accuracy—before clinical trials even begin. With Merck KGaA among those adopting this cutting-edge approach, the industry is moving toward a future where safer, more effective drugs reach patients faster. The shift is happening now. Read more: https://lnkd.in/dtAaByc8 #BioAI #DrugSafety #NoMoreGuesswork #FutureofMedicine #ClinicalTrials